About
Autologous mesenchymal stem cells, growth media
Areas of Focus
Categories
Non-PharmaceuticalSouthwestern U.S.
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
7
As Collaborator
0
Total Enrollment
160
By Phase
PHASE1/PHASE2: 4PHASE2: 1
By Status
COMPLETED: 2NO_LONGER_AVAILABLE: 2NOT_YET_RECRUITING: 1RECRUITING: 1WITHDRAWN: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT06654193Lead Sponsor
Allogeneic HB-adMSCs vs Placebo for the Treatment of Acute Kidney Injury
PHASE1/PHASE2Not yet recruiting
70 participants
Started: Oct 31, 2025 · Completed: Jan 1, 2028
NCT05951777Lead Sponsor
Autologous Adipose-Derived Mesenchymal Stem Cells for Chronic Traumatic Brain Injury
PHASE2Recruiting
51 participants
Started: Apr 16, 2024 · Completed: Dec 31, 2026
NCT04228666Lead Sponsor
A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) for the Treatment of Alzheimer's Disease
PHASE1/PHASE2Withdrawn
Started: Mar 1, 2020 · Completed: Feb 1, 2022
NCT04063215Lead Sponsor
A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy for the Treatment of Traumatic Brain Injury and Hypoxic-Ischemic Encephalopathy
PHASE1/PHASE2Completed
24 participants
Started: Jan 1, 2020 · Completed: Oct 25, 2024
NCT03691909Lead Sponsor
Phase 1/2a Clinical Trial to Assess the Safety of HB-adMSCs for the Treatment of Rheumatoid Arthritis
PHASE1/PHASE2Completed
15 participants
Started: Sep 25, 2018 · Completed: Sep 28, 2020
Locations (1)
Headquarters
Sugar Land, TX, United States
Map
Loading map...